Journal of clinical hypertension (Greenwich, Conn.)Aug 22, 2026

How Bedtime Blood Pressure Medicine Affects Nighttime Blood Pressure in Different Patient Types

Circadian Biology Weekly Brief ↗PubMed ↗DOI ↗OA ↗

Updated Aug 23, 2026

Abstract

Bedtime dosing of antihypertensive medications significantly reduces nighttime systolic blood pressure by 4.87 mmHg.

Nighttime diastolic blood pressure also decreases significantly with bedtime dosing, with a reduction of 2.80 mmHg.
In populations classified as non-dippers, the reductions in nighttime blood pressure are more pronounced, with a systolic reduction of 7.57 mmHg and diastolic reduction of 3.77 mmHg.
Higher baseline proportions of non-dippers (≥ 60%) are associated with nearly double the reduction in nighttime systolic blood pressure compared to lower proportions (< 60%)
Overall, bedtime antihypertensive dosing affects nocturnal blood pressure, but the effect size varies depending on the baseline prevalence of non-dippers in the study population.
The findings indicate variability in treatment effects across different trial populations, suggesting that responses to chronotherapy may not be uniform among all hypertensive individuals.

Simplified

Bedtime dosing of antihypertensive medications is associated with a reduction in nocturnal blood pressure (BP), but whether this effect is modified at the study level remains uncertain. We conducted an updated meta-analysis of randomized controlled trials comparing bedtime versus morning antihypertensive administration, evaluating the overall treatment effect and its potential modification by baseline non-dipper prevalence. PubMed, EMBASE, and the Cochrane Library were searched, with nighttime ambulatory systolic BP (SBP) and diastolic BP (DBP) as primary outcomes. Subgroup analyses were performed based on baseline non-dipper proportion (< 60% vs. ≥ 60%). Sixty-six RCTs involving 29,654 participants were included. In the overall hypertensive population, bedtime dosing significantly reduced nighttime SBP (WMD: 4.87 mmHg; 95% CI: 3.75-6.00) and DBP (WMD: 2.80 mmHg; 95% CI: 2.23-3.37), with modest reductions in 24 h SBP (WMD: 2.06 mmHg) and daytime SBP (WMD: 0.99 mmHg). In trials restricted to non-dippers, a more pronounced reduction in nighttime BP was observed (SBP WMD: 7.57 mmHg; DBP WMD: 3.77 mmHg). Similarly, study populations with a higher baseline proportion of non-dippers (≥ 60%) experienced approximately two-fold higher nighttime SBP reductions versus those with lower prevalence (< 60%) (WMD: ∼9.7 vs. 4.4 mmHg; p < 0.01), with a consistent pattern for nighttime DBP (5.1 vs. 2.6 mmHg; between-group p < 0.05). Bedtime antihypertensive dosing reduces nocturnal BP across the general hypertensive population; however, the magnitude of effect appears to be modified at the study level by baseline non-dipper prevalence. These findings suggest that chronotherapy effects are heterogeneous across trial populations rather than uniform across all hypertensive individuals.

Full Text

Full text is available at the source.

View Full Text ↗

How Bedtime Blood Pressure Medicine Affects Nighttime Blood Pressure in Different Patient Types

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the circadian biology brief